RecruitingNCT06769386

Investigation of Muscle Oxygenation in Patients With Rheumatoid Arthritis

Investigation of Respiratory Muscle Strength, Respiratory Muscle Endurance and Muscle Oxygenation in Patients With Rheumatoid Arthritis


Sponsor

Kirsehir Ahi Evran Universitesi

Enrollment

68 participants

Start Date

Jan 25, 2025

Study Type

OBSERVATIONAL

Conditions

Summary

The aim of this study is to investigate respiratory muscle strength, respiratory muscle endurance, muscle oxygenation, upper extremity and lower extremity exercise capacity in rheumatoid arthritis patients compared with healthy individuals.


Eligibility

Min Age: 18 YearsMax Age: 65 Years

Inclusion Criteria6

  • Rheumatoid Arthritis Group
  • Patients diagnosed with rheumatoid arthritis,
  • The ages of 18-65 years,
  • Volunteer to participate in the study will be included in the study.
  • The ages of 18-65 years,
  • Volunteer to participate in the study will be included in the study.

Exclusion Criteria10

  • Serious cardiopulmonary, neurological, neuromuscular, orthopedic and other systemic diseases or other diseases affecting physical functions,
  • Participated in a planned exercise program in the last three months,
  • Cognitive impairment that will cause difficulty in understanding and following exercise test instructions,
  • Contraindications to exercise testing or exercise training according to the American Sports Medicine Association will not be included in the study.
  • Control Group
  • Diagnosed chronic or systemic disease,
  • Regular exercise (physical activity) 3 days a week, 150 minutes/week of moderate intensity
  • Smoking 10 packs x years or more,
  • Pneumonia or any acute infection,
  • Healthy individuals with any psychiatric disorder will not be included in the study.

Locations(1)

Kırşehir Ahi Evran University, Physical Therapy and Rehabilitation Center, Cardiopulmonary Unit

Kırşehir, Merkez, Turkey (Türkiye)

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06769386


Related Trials